RenovoRx, Inc. (RNXT) has 23 open-market insider trades by 6 insiders since 2022. Over the last six months insiders net bought $20K. The most active filer is Ramtin Agah, Chief Medical Officer.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Ramtin Agah | Chief Medical Officer | — | 12 | $171K | 2026-01-21 |
| Shaun Bagai | CEO | — | 7 | $53K | 2025-12-18 |
| Mark Voll | CFO | — | 1 | $20K | 2026-09-10 |
| Laurence Marton | Dir | — | 1 | $10K | 2025-05-02 |
| Ron Kocak | Controller | — | 1 | $10K | 2025-04-10 |
| Angela Nelms | COO | — | 1 | $1K | 2023-10-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mark Voll | CFO | Buy | $20K | 2026-05-19 |
| Ramtin Agah | Chief Medical Officer | Buy | $10K | 2026-01-21 |
| Ramtin Agah | Chief Medical Officer | Buy | $8K | 2025-12-31 |
| Ramtin Agah | Chief Medical Officer | Buy | $170 | 2025-12-30 |
| Shaun Bagai | CEO | Buy | $5K | 2025-12-18 |
| Shaun Bagai | CEO | Buy | $4K | 2025-12-17 |
Companies that share insiders with RNXT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Ramtin Agah | Chief Medical Officer | Buy | $10K | 2025-12-16 |
| Ramtin Agah | Chief Medical Officer | Buy | $10K | 2025-12-05 |
| Ramtin Agah | Chief Medical Officer | Buy | $18K | 2025-11-21 |
| Shaun Bagai | CEO | Buy | $9K | 2025-08-22 |
| Ramtin Agah | Chief Medical Officer | Buy | $29K | 2025-06-05 |
| Ramtin Agah | Chief Medical Officer | Buy | $14K | 2025-04-15 |
| Shaun Bagai | CEO | Buy | $7K | 2025-04-15 |
| Ramtin Agah | Chief Medical Officer | Buy | $16K | 2025-04-11 |
| Ramtin Agah | Chief Medical Officer | Buy | $24K | 2025-04-09 |